Elkington and Fife LLP is a
leading firm of patent and trade mark attorneys dealing with all areas
of technology. The firm has offices in Central London and
Sevenoaks, Kent. Elkington and Fife LLP was founded
in 1927 and was one of the first firms in the UK to offer specialist
expertise in the field of chemistry.
From its original specialisation in chemistry, Elkington and Fife LLP now has a
well established reputation covering all areas of technology and all
areas of intellectual property. The attorneys in the firm all
have technical university degrees which currently cover the fields of
chemistry, physics, biochemistry, pharmacology, electronics and civil
The firm represents a number of multinational corporations as
well as many small and medium-sized companies, and
individuals. The firm also works with firms of attorneys
principally in the US, Japan and Korea. Elkington and Fife LLP at present
has nine partners. The chemical side of the firm has five
partners (Jim Marchant, Diana Kyle, Clive Froud, Gordon Wright and
Richard Gillard) and three trainee attorneys (Simon Thomas, Amanda
McGowan and Helen Brearley). The electrical/mechanical side
of the firm has three partners (Graham Boon, Nick Ertl and Simon
Greene) and one trainee attorney (James Anderson). One
partner (Peter Charlton) divides his time between patent and trade mark
work and has a trade mark associate (Mark Hiddleston) and a
part-qualified trainee (Katie Cameron).
The services offered by Elkington and Fife LLP include the preparation, filing and prosecution of UK, European and international patent applications, as well as UK, Community and foreign trade mark and registered design applications. We have extensive experience of opposition and appeal proceedings before the European Patent Office.
We also give infringement and validity advice for patents, trade marks and registered designs as well as opinions relating to design right, industrial copyright and passing off issues. We have assisted our clients in numerous patent and trade mark disputes over the years, such as Genentech's Patent.